Drug Companies Update May 2008
Mergers, acquisitions & Joint Ventures
- EUSA Pharma has acquired Cytogen, which is to remain a subsidiary.
- Evotec has acquired Renovis which is to remain a wholly-owned subsidiary.
- Oragenics has changed its name to ONI BioPharma.
- Takeda has acquired Millenium, which is to remain an indirect wholly-owned subsidiary.
- Pfizer has acquired Serenex.
New Companies
- Akebia is a spin-off company from Proctor & Gamble focused on the development of treatments for ischaemia and improvement of vascular disease.
- Alfama is a pharmaceutical company dedicated to the development of small-molecule drugs to combat inflammation-related diseases.
- Alize Pharma is a group of privately-held biopharmaceuticals specializing in the development of therapeutics for metabolic diseases and cancer.
- CellCeutix is a biopharmaceutical company engaged in the development of treatments for cancer and inflammatory diseases.
- CureDM is a biopharmaceutical company engaged in the development of therapies to prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
- Espirion Therapeutics is a spin-off company from Pfizer that develops compounds for cardiovascular and metabolic diseases.
- Frontier Biotechnologies is focused on the development of peptide-based drugs for the treatment of infectious diseases.
- Genelux is a privately-held biomedical company focused on the development of diagnostic and therapeutic solutions for cancer and inflammatory diseases for which no effective treatment exists.
- GlyaNova is a Norwegian biopharmaceutical company developing compounds derived from medical mushrooms, particularly polysaccharides which stimulate the immune system.
- Hy BioPharma develops and commercializes a drug technology for the treatment of cancer, autoimmune disorders and inflammation.
- IntelliPharmaCeutics designs and develops controlled-release drugs. It develops both in house products and partnered products, using a proprietary drug delivery technology.
- Madeira Therapeutics specializes in the reformulation of off-patent drugs for use in the paediatric population.
- Mirna Therapeutics is a privately owned biotechnology company focused on the development of microRNA therapeutics.
- Niconovum develops rapidly-acting nicotine replacement therapies for the treatment of smoking cessation.
- Opal Therapeutics is developing novel HIV and hepatitis C vaccines.
- PharmaNeuroBoost is focused on the development of CNS therapies, primarily combinations of its proprietary drug pipamperone.
- Pulmo BioTech is developing a range of molecular imaging agents based on nuclear medicine for the imaging on the circulatory system of the lungs.
- Quantum Immunologics develops ‘designer’ therapeutics for immune diseases and cancer.
- Solmap Pharmaceuticals is a drug discovery and design company, developing novel small molecule drugs and enhancing existing small molecules in a wide range of therapeutic areas.
- ViroStatics is a biotechnology company focusing on the development of immunotherapeutics for the treatment of HIV/AIDS and viral infections.
- Znomics is developing new pharmaceutical products for the treatment of human diseases, using its zebra-fish based drug discovery platform.
